Survival Benefits of Coronary-Artery Bypass Grafting
Author Information
Author(s): Sobolev Boris G, Fradet Guy, Hayden Robert, Kuramoto Lisa, Levy Adrian R, FitzGerald Mark J
Primary Institution: The University of British Columbia
Hypothesis
Does coronary-artery bypass grafting (CABG) reduce mortality compared to untreated patients?
Conclusion
CABG significantly improves survival, especially when performed early.
Supporting Evidence
- One in 10 patients died during the five years after treatment decision.
- The hazard of death among patients who underwent CABG was 51 percent of that for the untreated group.
- The effect was stronger when CABG was performed within the recommended time.
- Adjusted hazard ratios were 0.43 for early and 0.58 for late intervention.
Takeaway
Getting heart surgery can help people live longer, especially if they have it done quickly.
Methodology
The study used a population-based registry to compare survival rates between patients who underwent CABG and those who remained untreated.
Potential Biases
Potential biases include underreporting of comorbid conditions and inaccuracies in coding dates.
Limitations
The study is observational and may not account for all confounding factors affecting survival.
Participant Demographics
The cohort included adult residents of British Columbia with established coronary artery disease.
Statistical Information
P-Value
<0.001
Confidence Interval
0.43 to 0.61
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website